Monte Rosa Therapeutics Inc (GLUE)

Investing Cash Flow

-$316.79M

TTM · Period ending: · USD

GLUE logo

GLUE Investing Cash Flow

Latest reported-$316.79M
GLUE Cash from Investing (-$1.39M → -$316.79M)
High-resolution chart · PNG

GLUE investing cash flow history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Monte Rosa Therapeutics Inc Investing Cash Flow — Annual fiscal periods (USD)
Period endingInvesting Cash Flow (USD)
-101,833,000
-44,452,000
88,801,000
-219,219,000
-9,653,000
-3,389,000
-1,385,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.